Treatment and Prevention Options for Rhinovirus Infection
Rhinovirus infections should be managed primarily with symptomatic treatment and preventive measures, as there are currently no approved antiviral agents for clinical use. 1, 2
Diagnosis and Clinical Assessment
- Consider bacterial superinfection only when:
- Symptoms persist ≥10 days without improvement
- Severe symptoms with high fever (≥39°C) and purulent discharge for 3-4 consecutive days
- "Double-sickening" pattern (initial improvement followed by worsening) 1
- Diagnostic testing:
Treatment Options
Symptomatic Treatment
Hydration
- Maintain adequate hydration (though limited evidence exists for increased fluid intake) 1
Nasal Symptoms Management
Cough Management
Pain and Fever Control
Antibiotics
Prevention Strategies
Hand Hygiene
Infection Control Measures
- Mask use during outbreaks 1
- Social distancing during outbreaks 1
- Use of virucidal facial tissues to smother aerosols generated by coughing, sneezing, and nose blowing 4
- Avoid exposing infants to passive smoking 3
- Restrict healthcare personnel with upper respiratory infections from caring for high-risk patients 3
- Limit visitors with respiratory symptoms from visiting pediatric, immunosuppressed, or cardiac patients 3
Special Considerations
High-Risk Populations
- Infants and young children: Avoid over-the-counter cold medications in children under 4 years 1, 5
- Elderly patients: Require closer monitoring due to increased risk of complications 1, 5
- Patients with asthma or COPD: At higher risk for exacerbations and complications 6, 5, 7
- Immunocompromised patients: May experience persistent infections and more severe disease 1, 5
When to Seek Further Medical Attention
Return for medical evaluation if:
- Fever >38°C persists for more than 48 hours
- Breathing difficulty develops
- Symptoms worsen after initial improvement 1
Future Therapeutic Approaches
Research is ongoing for:
- Antiviral drugs targeting rhinovirus capsid proteins 2, 7
- Small molecule inhibitors of rhinovirus infection 2
- Antiviral host defense peptides 2
Despite being the world's leading cause of respiratory illness, rhinoviruses are relatively inefficient transmitters, infecting only about 50% of susceptible individuals in family settings 4. This offers hope that proper preventive measures can significantly reduce transmission.